Go Deep
Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -23,478 | -0.2 | -11.31 | -2.90 | 297.40 |
| Oct 2026 | -23,046 | -0.2 | -10.47 | -2.90 | 275.15 |
| Oct 2026 | -24,961 | -0.1 | -9.91 | -2.90 | 260.75 |
| Oct 2026 | -25,053 | -0.1 | -10.09 | -2.90 | 265.49 |
| Oct 2026 | -25,016 | -0.1 | -10.02 | -2.90 | 262.94 |
| Oct 2026 | -24,648 | -0.1 | -9.29 | -2.90 | 243.53 |
Jupiter Neurosciences, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 24,245.0 | 18,652.0 | 21,796.0 | 0.0 |
| Net Profit | -2,274,397.0 | -2,061,958.0 | -2,575,031.0 | -2,288,034.0 |
| EPS | -4.1 | -4.5 | — | -5.2 |
Jupiter Neurosciences, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 21,796.0 | 0.0 | 0.0 | 233,281.0 | — |
| Net Profit | -8,644,897.0 | -2,439,625.0 | -4,783,689.0 | -4,957,580.0 | — |
| EPS | -18.8 | -6.0 | -13.5 | -11.3 | — |
Jupiter Neurosciences, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 5,564,030.0 | 6,202,409.0 | 148,592.0 | 235,944.0 | — |
| Total Liabilities | 7,395,882.0 | 2,030,401.0 | 5,949,946.0 | 7,380,028.0 | — |
| Total Equity | -1,831,852.0 | 4,172,008.0 | -5,801,354.0 | -7,144,084.0 | — |
Owes vs Owns
Jupiter Neurosciences, Inc. owed $1.10 for every $1 it owned in Jun 2026, down from $31.3 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 1.10× | 1.33× | 0.33× | 40.0× | 31.3× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Jupiter Neurosciences, Inc. Assets & Liabilities Breakdown (₹ Cr)
What it owns — Dec 2025
Cash & short-term investments 68.1%Inventory 2.9%Other assets 28.6%
How it's funded — Dec 2025
Short-term debt 71.6%Payables 1.8%Other liabilities 26.6%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 0.4 | 0.4 | 0.0 | 0.0 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.0 | 0.0 | 0.0 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.2 | 0.2 | 0.0 | 0.0 |
| Liabilities & equity | ||||
| Short-term debt | 0.5 | 0.0 | 0.2 | 0.2 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 0.0 | 0.0 | 0.0 | 0.0 |
| Other liabilities | 0.2 | 0.2 | 0.4 | 0.5 |
| Shareholders' equity | -0.2 | 0.4 | -0.6 | -0.7 |
| Net tangible assets | -0.2 | 0.4 | -0.6 | -0.7 |
Jupiter Neurosciences, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -5,413,736.0 | -3,911,004.0 | -480,953.0 | -1,248,504.0 | — |
| Financing Activities | 5,433,568.0 | 7,652,036.0 | 445,000.0 | 982,333.0 | — |